{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lawrence",
      "state": "MA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "81445",
      "recalling_firm": "NxStage Medical, Inc.",
      "address_1": "350 Merrimack St",
      "address_2": "N/A",
      "postal_code": "01843-1748",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide Distribution.",
      "recall_number": "Z-0502-2019",
      "product_description": "NxStage PureFlow B Solution-RFP-402, Premixed Dialysate for Hemodialysis     NxStage PureFlow B Solution is indicated for use with renal replacement therapy systems that utilize sterile premixed dialysate during hemodialysis.",
      "product_quantity": "21071",
      "reason_for_recall": "PureFlow B Solution smaller chamber of the two chamber  bag can burst electrolyte fluid and cause injury if it comes in contact with the eyes or skin",
      "recall_initiation_date": "20181017",
      "center_classification_date": "20181127",
      "termination_date": "20200826",
      "report_date": "20181205",
      "code_info": "Lot Numbers:  F1708255, F1709285, F1710323, Q1711861, Q1711863, Q1712021, Q1712022, Q1712023, Q1712033,  Q1801345, Q1802399, Q1802400"
    }
  ]
}